Tag Archives: structured M&A

Neuroscience Deal Doublet: Both Quartet and Rodin Strike Transformative Partnerships
January 6, 2016

We’re excited to announce two new collaborations today from our neuroscience portfolio – Quartet with Merck (here) and Rodin with Biogen (here) – to advance their programs into early clinical development.  These are both young companies that we helped create

Leave a comment